Related Experiment Videos

Mucha-Habermann disease in children -- the association with rheumatic diseases

Insights

Mucha-Habermann disease, a rare condition, can manifest in infants with progressive juvenile rheumatoid arthritis or polyarthritis. Corticosteroids may help skin symptoms, while joint issues show varied responses in children.

Area of Science:

  • Pediatric Rheumatology
  • Dermatology
  • Immunology

Background:

  • Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta) is a rare, chronic inflammatory condition.
  • Its presentation and progression in pediatric patients require further elucidation.

Observation:

  • Two infant cases of Mucha-Habermann disease are presented.
  • One involved a boy with progressive juvenile rheumatoid arthritis over a decade, with partial response of skin lesions to low-dose corticosteroids.
  • The other involved a girl with polyarthritis and rash, which resolved spontaneously over years, followed by scleroderma and recurrent skin lesions.

Findings:

  • Mucha-Habermann disease can present with diverse rheumatologic manifestations in children.
  • The course can be chronic and progressive, as seen in the juvenile rheumatoid arthritis case.
  • Responses to treatment and disease evolution, including development of other autoimmune conditions like scleroderma, can vary significantly.

Implications:

  • Highlights the complex interplay between skin and joint manifestations in Mucha-Habermann disease.
  • Suggests the need for long-term monitoring of pediatric patients with this condition.
  • Underscores the potential for evolving clinical phenotypes and associated autoimmune comorbidities.

Related Concept Videos